Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: A systematic literature analysis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue 6, 2010, Pages 733-740

  Illueca, Marta ^a   Wernersson, Börje ^a   Henderson, Catherine ^b   Lundborg, Per ^a  

^a ASTRAZENECA   (United Kingdom)

^b OXFORD PHARMAGENESIS LTD   (United Kingdom)

Author keywords

gastroesophageal reflux disease; maintenance treatment; pediatric; proton pump inhibitor; reflux esophagitis

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; RANITIDINE;

AGITATION; ARTICLE; COMORBIDITY; CONSTIPATION; DATA BASE; DIARRHEA; DRUG FATALITY; DRUG MEGADOSE; FOLLOW UP; HUMAN; IRRITABILITY; MAINTENANCE THERAPY; NAUSEA AND VOMITING; PRIORITY JOURNAL; RASH; REFLUX ESOPHAGITIS; RELAPSE; SIDE EFFECT; SINGLE DRUG DOSE;

ANTI-ULCER AGENTS; CHILD; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HUMANS; OMEPRAZOLE; OUTCOME ASSESSMENT (HEALTH CARE); PROTON PUMP INHIBITORS; RECURRENCE;

EID: 78650515564     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181e2acfd     Document Type: Article

References (37)

1. Vakil N, Veldhuyzen van Zanten S, Kahrilas P, et al. The Montreal definition and classification of gastro-esophageal reflux disease (GERD)-a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20.
2. Armstrong D. Systematic review: Persistence and severity in gastroesophageal reflux disease. Aliment Pharmacol Ther 2008;28: 841-53.
3. Donnellan C, Sharma N, Preston C, et al. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2005;4:CD003245.
4. Klinkenberg-Knol EC, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000;118:661-9.
5. Gilger MA, Tolia V, Vandenplas Y, et al. Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2008;46:524-33.
6. Hassall E, Israel D, Shepherd R, et al. Omeprazole for treatment of chronic erosive esophagitis in children: A multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group. J Pediatr 2000;137:800-7.
7. Tolia V, Ferry G, Gunasekaran T, et al. Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr 2002;35(Suppl 4):S308-18.
8. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: Joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009;49:498-547.
9. Boccia G, Manguso F, Miele E, et al. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: Is it advisable? Am J Gastroenterol 2007;102:1291-7.
10. Bohmer CJ, Niezen-de Boer RC, Klinkenberg-Knol EC, et al. Omeprazole: Therapy of choice in intellectually disabled children. Arch Pediatr Adolesc Med 1998;152:1113-8.
11. Hassall E. Omeprazole for maintenance therapy of erosive esophagitis in children. Gastroenterology 2000;118:A658.
12. Pashankar D, Blair GK, Israel DM. Omeprazole maintenance therapy for gastroesophageal reflux disease after failure of fundoplication. J Pediatr Gastroenterol Nutr 2001;32:145-9.
13. Pashankar DS, Israel DM. Gastric polyps and nodules in children receiving long-term omeprazole therapy. J Pediatr Gastroenterol Nutr 2002;35:658-62.
14. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95:903-12.
15. Savary M, Miller G. The oesophagus. In: Handbook and Atlas of Endoscopy. Solothorn, Switzerland: Gassman AG; 1978.
16. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr 2007;150:262-7.
17. De Giacomo C, Bawa P, Franceschi M, et al. Omeprazole for severe reflux esophagitis in children. J Pediatr Gastroenterol Nutr 1997;24: 528-32.
18. Cucchiara S, Minella R, Campanozzi A, et al. Effects of omeprazole on mechanisms of gastroesophageal reflux in childhood. Dig Dis Sci 1997;42:293-9.
19. Krischer J, Noblett H, Sandhu BK. The use of proton pump blocker for resistant reflux oesophagitis in children. Gut 1992;33:S61.
20. Sherman PM, Hassall E, Fagundes-Neto U, et al. A global, evidencebased consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 2009;104:1278-95.
21. Strauss RS, Calenda KA, Dayal Y, et al. Histological esophagitis: Clinical and histological response to omeprazole in children. Dig Dis Sci 1999;44:134-9.
22. Orenstein SR, Shalaby TM, Kelsey SF, et al. Natural history of infant reflux esophagitis: Symptoms and morphometric histology during one year without pharmacotherapy. Am J Gastroenterol 2006;101:628-40.
23. Hassall E, Owen D, Kerr W, et al. Gastric histology in children treated with proton pump inhibitors (PPIs) long-term. Gastroenterology 2008;134(4 Suppl 1):A174.
24. Tolia V, Boyer K. Long-term proton pump inhibitor use in children: A retrospective review of safety. Dig Dis Sci 2008;53:385-93.
25. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut 1999; 44(Suppl 2):S1-6.
26. Waring JP, Feiler MJ, Hunter JG, et al. Childhood gastroesophageal reflux symptoms in adult patients. J Pediatr Gastroenterol Nutr 2002; 35:334-8.
27. Young RJ, Lyden E, Ward B, et al. A retrospective, case-control pilot study of the natural history of pediatric gastroesophageal reflux. Dig Dis Sci 2007;52:457-62.
28. El-Serag HB, Richardson P, Pilgrim P, et al. Determinants of gastroesophageal reflux disease in adults with a history of childhood gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2007;5:696-701.
29. Tolia V, Gilger M, Barker PN, et al. Healing of erosive esophagitis (EE) and improvement in symptoms of gastroesophageal reflux disease (GERD) in 1- and 2-year-old children after esomeprazole treatment. Gastroenterology 2007;132(4 Suppl 2):670.
30. Tolia V, Youssef NN, BelknapW, et al. Treatment of erosive esophagitis with esomeprazole in children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2006;43:E20.
31. Labenz J, Armstrong D, Lauritsen K, et al. A randomized comparative study of esomeprazole 40mg versus pantoprazole 40mg for healing erosive oesophagitis: The EXPO study. Aliment Pharmacol Ther 2005; 21:739-46.
32. Castell DO, Kahrilas PJ, Richter JE, et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 2002;97:575-83.
33. Richter JE, Kahrilas PJ, Johanson J, et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: A randomized controlled trial. Am J Gastroenterol 2001;96:656-65.
34. Kahrilas PJ, Falk GW, Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: A randomized controlled trial. The Esomeprazole Study Investigators. Aliment Pharmacol Ther 2000;14: 1249-58.
35. Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol 2005;40:275-85.
36. Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: Loiano-Monghidoro study. Gut 2008;57:1354-9.
37. Ruigómez A, Wallander M-A, Lundborg P, et al. Gastroesophageal reflux disease in children and adolescents in primary care. Scand J Gastroenterol 2010;45:139-46.